Medicskin Holdings sets board meeting to review interim results, dividend recommendation

• Medicskin schedules a board meeting for Nov. 24, 2026 to review unaudited interim results for the six months ended Sept. 30, 2026.
• Directors will also consider an interim dividend recommendation at the meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicskin Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260929-12351538), on September 29, 2026, and is solely responsible for the information contained therein.